Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

9.1%

2 terminated out of 22 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

18%

4 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed with results

Key Signals

3 with results78% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (11)
P 1 (2)
P 3 (2)
P 4 (2)

Trial Status

Completed7
Recruiting5
Unknown4
Not Yet Recruiting2
Terminated2
Withdrawn2

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07541404Not ApplicableNot Yet RecruitingPrimary

MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma

NCT07258069RecruitingPrimary

Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

NCT06724029Recruiting

Neurosurgical Outcome Network

NCT04923984Not ApplicableRecruitingPrimary

Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)

NCT04402632Not ApplicableCompletedPrimary

Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma

NCT07143799Not ApplicableRecruitingPrimary

Scalp Block Versus General Anesthesia in Patients Undergoing Evacuation of Subdural Hematoma Via Burr Hole

NCT06067750Completed

Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation

NCT05713630Phase 3Not Yet RecruitingPrimary

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma

NCT05649904Not ApplicableRecruiting

AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

NCT05472766Not ApplicableTerminatedPrimary

Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma

NCT04270955Not ApplicableCompleted

Dartmouth Middle Meningeal Embolization Trial (DaMMET)

NCT04500795Not ApplicableWithdrawn

Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma

NCT06119932UnknownPrimary

Evaluation of One Burr Hole Evacuation for Subdural Hematoma

NCT06052124Not ApplicableUnknownPrimary

Augmented Reality for Subdural Drain Placement

NCT04170582Unknown

Patient Registry for Patients With Chronic Subdural Hematoma

NCT03153150Phase 3Completed

Start or STop Anticoagulants Randomised Trial (SoSTART)

NCT02618382Phase 4CompletedPrimary

A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population

NCT03496545Phase 1Completed

Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury

NCT04211233Not ApplicableUnknown

Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE)

NCT02368366Not ApplicableCompleted

Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI

Scroll to load more

Research Network

Activity Timeline